GSK1325760A ( DrugBank: - )

---

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	2

86. 肺動脈性肺高血圧症

---

臨床試験数 : 1,205 /  薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00554619 (ClinicalTrials.gov)	February 2008	5/11/2007	A Study to Evaluate GSK1325760A - a Long-Term Extension Study	Study AMB107818, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An Open Label Study of GSK1325760A to Evaluate the Safety and Efficacy of GSK1325760A - a Long-term Extension Study -	Pulmonary Arterial Hypertension;Hypertension, Pulmonary	Drug: GSK1325760A	GlaxoSmithKline	NULL	Completed	N/A	N/A	All	21	Phase 3	Japan
2	NCT00540436 (ClinicalTrials.gov)	August 2007	5/10/2007	Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension	Study AMB107816, Clinical Evaluation of GSK1325760A in the Treatment of Pulmonary Arterial Hypertension (PAH)- An Open-Label Phase II/III Study to Evaluate the Efficacy, Safety and Pharmacokinetics of GSK1325760A -	Hypertension, Pulmonary	Drug: GSK1325760A	GlaxoSmithKline	NULL	Completed	18 Years	N/A	All	25	Phase 2	Japan